Nucleic acid constructs

Details for Australian Patent Application No. 2004279991 (hide)

Owner PowderJect Vaccines, Inc.

Inventors Fuller, James

Agent Spruson & Ferguson

Pub. Number AU-B-2004279991

PCT Pub. Number WO2005/035771

Priority 60/509,936 10.10.03 US

Filing date 11 October 2004

Wipo publication date 21 April 2005

Acceptance publication date 25 November 2010

International Classifications

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07K 14/02 (2006.01) Peptides having more than 20 amino acids

C07K 14/035 (2006.01) Peptides having more than 20 amino acids

C07K 14/045 (2006.01) Peptides having more than 20 amino acids

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/62 (2006.01) Peptides having more than 20 amino acids

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/035771 Priority application(s): WO2005/035771

25 November 2010 Application Accepted

  Published as AU-B-2004279991

24 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004279992-Castable magnesium alloys

2004279990-Modified whole cell, cell extract and OMV-based vaccines